论文部分内容阅读
Ｂｅｔａｆｅｃｔｉｎ开始Ⅲ期临床试验Ⅱ期临床研究表明，Ａｉｐｈａ－Ｂｅｔａ技术公司的ｂｅｔａｆｅｃｔｉｎ（β－葡聚糖重组产品）能显著降低高危病人术后感染率。本品的Ⅲ期临床试验即将开始。分析家们认为，ｂｅｔａｆｅｃｔｉｎ两项Ⅱ期临床试验的成功为Ａｉｐｈ...
Betafectin Phase III Clinical Trials Phase II clinical studies have shown that Aipha-Beta’s betafectin (beta-glucan recombinant) significantly reduces postoperative infection in high-risk patients. Phase Ⅲ clinical trials of this product is about to begin. Analysts believe that the success of two phase II clinical trials of betafectin is Aiph ...